D. Nenciu

Drug development of intranasally delivered peptides.

Bruce H. Morimoto, A. Fox, C. Campbell, 2012, Therapeutic delivery.

Health benefits of soy proteins analysis and their influence on the quality of fortified bread

E. Condrea, D. Nenciu, M. Constandache, 2012 .

Considerations Regarding the Quality Management of Banking Services

A. Stanciu, D. Nenciu, M. Constandache, 2016 .

Rucaparib in patients presenting a metastatic breast cancer with homologous recombination deficiency, without germline BRCA1/2 mutation.

I. Bièche, F. André, O. Trédan, 2020, European journal of cancer.

RUBY: A phase II study testing rucaparib in germline (g) BRCA wild-type patients presenting metastatic breast cancer (mBC) with homologous recombination deficiency (HRD).

I. Bièche, F. André, O. Trédan, 2019, Journal of Clinical Oncology.